Your browser doesn't support javascript.
SARS-CoV-2/COVID-19 Testing: The Tower of Babel.
Reno, Chiara; Lenzi, Jacopo; Golinelli, Davide; Gori, Davide; Signorelli, Carlo; Kraemer, John; Stoto, Michael A; Avitabile, Elisa; Landini, Maria Paola; Lazzarotto, Tiziana; Re, Maria Carla; Rucci, Paola; Taliani, Gloria; Trerè, Davide; Vocale, Caterina; Fantini, Maria Pia.
  • Reno C; Dipartimento di Scienze Biomediche e Neuromotorie, Alma Mater Studiorum - Università di Bologna. chiara.reno@studio.unibo.it.
  • Lenzi J; Dipartimento di Scienze Biomediche e Neuromotorie, Alma Mater Studiorum - Università di Bologna. jacopo.lenzi2@unibo.it.
  • Golinelli D; Dipartimento di Scienze Biomediche e Neuromotorie, Alma Mater Studiorum - Università di Bologna. davide.golinelli@unibo.it.
  • Gori D; Dipartimento di Scienze Biomediche e Neuromotorie, Alma Mater Studiorum - Università di Bologna. davide.gori4@unibo.it.
  • Signorelli C; Università Vita-Salute San Raffaele; Dipartimento di Medicina e Chirurgia, Università degli Studi di Parma. signorelli.carlo@hsr.it.
  • Kraemer J; Department of Health Systems Administration, Georgetown University. jdk32@georgetown.edu.
  • Stoto MA; Department of Health Systems Administration, Georgetown University; Emergency Preparedness Research, Evaluation and Practice (EPREP) Program, Harvard T.H. Chan School of Public Health. mikestoto@gmail.com.
  • Avitabile E; Dipartimento di Farmacia e Biotecnologie, Alma Mater Studiorum - Università di Bologna. elisa.avitabile@unibo.it.
  • Landini MP; IRCCS Istituto Ortopedico Rizzoli; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Alma Mater Studiorum - Università di Bologna. mariapaola.landini@ior.it.
  • Lazzarotto T; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Alma Mater Studiorum - Università di Bologna, Bologna. tiziana.lazzarotto@unibo.it.
  • Re MC; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Alma Mater Studiorum - Università di Bologna. mariacarla.re@unibo.it.
  • Rucci P; Dipartimento di Scienze Biomediche e Neuromotorie, Alma Mater Studiorum - Università di Bologna. paola.rucci2@unibo.it.
  • Taliani G; Dipartimento di Medicina Traslazionale e di Precisione, Università degli Studi di Roma "La Sapienza". gloria.taliani@uniroma1.it.
  • Trerè D; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Alma Mater Studiorum - Università di Bologna. davide.trere@unibo.it.
  • Vocale C; IRCCS Azienda Ospedaliero-Universitaria "Policlinico Sant'Orsola-Malpighi" di Bologna. caterina.vocale@aosp.bo.it.
  • Fantini MP; Dipartimento di Scienze Biomediche e Neuromotorie, Alma Mater Studiorum - Università di Bologna. mariapia.fantini@unibo.it.
Acta Biomed ; 91(4): e2020144, 2020 11 09.
Article in English | MEDLINE | ID: covidwho-1058719
ABSTRACT
BACKGROUND AND

AIM:

Testing represents one of the main pillars of public health response to SARS-CoV-2/COVID-19 pandemic. This paper shows how accuracy and utility of testing programs depend not just on the type of tests, but on the context as well.

METHODS:

We describe the testing methods that have been developed and the possible testing strategies; then, we focus on two possible methods of population-wide testing, i.e., pooled testing and testing with rapid antigen tests. We show the accuracy of split-pooling method and how, in different pre-test probability scenarios, the positive and negative predictive values vary using rapid antigen tests.

RESULTS:

Split-pooling, followed by retesting of negative results, shows a higher sensitivity than individual testing and requires fewer tests. In case of low pre-test probability, a negative result with antigen test could allow to rule out the infection, while, in case of a positive result, a confirmatory molecular test would be necessary.

CONCLUSIONS:

Test performance alone is not enough to properly choose which test to use; goals and context of the testing program are essential. We advocate the use of pooled strategies when planning population-wide screening, and the weekly use of rapid tests for close periodic monitoring in low-prevalence populations.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Testing / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Language: English Journal: Acta Biomed Journal subject: Medicine Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Testing / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Language: English Journal: Acta Biomed Journal subject: Medicine Year: 2020 Document Type: Article